Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The ferroxidase HEPHaestin in Lung cancer: Pathological Significance and Prognostic Value

Paola Zacchi, Beatrice Belmonte, Alessandro Mangogna, Gaia Morello, Letizia Scola, Anna Martorana, Violetta Borelli
doi: https://doi.org/10.1101/2021.01.22.21250298
Paola Zacchi
1Department of Life Sciences, University of Trieste, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatrice Belmonte
2Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandro Mangogna
3Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaia Morello
2Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Letizia Scola
4Clinical Pathology, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, 90100 Palermo, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Martorana
2Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Violetta Borelli
1Department of Life Sciences, University of Trieste, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: borelliv{at}units.it
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: January 2021 to June 2025

AbstractFullPdf
Jan 2021232140
Feb 2021370634
Mar 20211021118
Apr 202179711
May 202187717
Jun 202174117
Jul 20213666
Aug 20212194
Sep 202136012
Oct 202137615
Nov 202145714
Dec 20212701
Jan 20221645
Feb 20221643
Mar 20222331
Apr 20222221
May 202216212
Jun 20222103
Jul 20222411
Aug 20222314
Sep 20223114
Oct 20222913
Nov 20221423
Dec 20221425
Jan 20231414
Feb 20231431
Mar 2023922
Apr 20232042
May 20231116
Jun 2023943
Jul 20231234
Aug 202314124
Sep 20231472
Oct 20231000
Nov 2023623
Dec 20231000
Jan 2024511
Feb 20241323
Mar 20241183
Apr 20241141
May 20245411
Jun 2024824
Jul 20241346
Aug 202413411
Sep 20242158
Oct 20241262
Nov 2024906
Dec 2024814
Jan 20251055
Feb 20258292
Mar 202514317
Apr 20251237
May 202514136
Jun 202518108
Back to top
PreviousNext
Posted January 25, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The ferroxidase HEPHaestin in Lung cancer: Pathological Significance and Prognostic Value
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The ferroxidase HEPHaestin in Lung cancer: Pathological Significance and Prognostic Value
Paola Zacchi, Beatrice Belmonte, Alessandro Mangogna, Gaia Morello, Letizia Scola, Anna Martorana, Violetta Borelli
medRxiv 2021.01.22.21250298; doi: https://doi.org/10.1101/2021.01.22.21250298
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The ferroxidase HEPHaestin in Lung cancer: Pathological Significance and Prognostic Value
Paola Zacchi, Beatrice Belmonte, Alessandro Mangogna, Gaia Morello, Letizia Scola, Anna Martorana, Violetta Borelli
medRxiv 2021.01.22.21250298; doi: https://doi.org/10.1101/2021.01.22.21250298

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)